CD8A and hepatocellular carcinoma: In a study of hepatocellular carcinoma (HCC) in vitro, Siglec-1-positive macrophages significantly enhanced CD8+ T-cell proliferation, cytotoxicity, and cytokine production, which was associated with a better clinical prognosis [12].